FDA Withdraws Proposal for Liability for Generic Drug Makers

The Supreme Court’s preemption cases shield generic pharmaceutical manufacturers from liability.  In 2013, the FDA proposed a new federal rule that would have allowed liability against manufacturers of generic drugs.  Last week, the FDA withdrew that proposal.  The Wall Street Journal has details.